COVID-19 UPDATE: Regenexx is committed to the health and safety of our patients. You may now be seen in clinic or via telemedicine for virtual/online or phone visits.
Our physicians are available via telemedicine to continue to give you the care you need during this difficult time. Learn more.

Still Recruiting for our Rotator Cuff Study…

By /

Regenexx Rotator Cuff Study

You may be eligible for the our Rotator Cuff Study if you’re between the ages of 18 and 65 years of age and have a rotator cuff tear.  This is a Regenexx clinical trial that is no cost to you. This Regenexx study is a true randomized trial, so you will receive either a stem cell injection or physical therapy, but at 3 months you’ll be able to cross over to the stem cell group if you’re randomized into the therapy group. If you have an interest, contact us at [email protected].

Get health and wellness information from a trusted source.

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Is Regenexx Right For You?

Request a free Regenexx Info Packet


Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar


Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog


9035 Wadsworth Pkwy #1000
Westminster, CO 80021


Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.